ClinicalTrials.gg
Enrolling by invitationNCT07356180Updated Jan 21, 2026

Physical Acvitiy in Pregnancy

An observational study in Pregnant Women, Gestational Diabetes and Obese But Otherwise Healthy Participants, sponsored by University of Maryland, Baltimore. Enrolling by invitation at 1 site in United States. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by University of Maryland, Baltimore · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 251 studies in Diabetes, Gestational with a site in United States — 52 open to participants now, 65 under way, 2 of them phase 3. Diabetes, Gestational · United States.

Planned enrollment
39th of 57
40 · median 72
Started
2023
with 18 others
Observational
57 of 251
10 open now
Primary completion
2026-12
later than 27 of 64 live
Registered
242nd of 251
by date

Among the 251 studies in Diabetes, Gestational with a site in United States, this one is the 39th largest by planned enrollment of the 57 observational ones that give a count, is one of 19 that started in 2023, is one of 57 observational ones, reaches primary completion later than 27 of the 64 other live ones, and was the 242nd registered.

Diabetes, Gestational

878 studies on the registry are indexed under Diabetes, Gestational; 196 are open to participants now.

Browse Diabetes, Gestational studies →

Open to participants now

52 of the 251 studies in Diabetes, Gestational with a site in United States are open now. Recruiting first, the newest first:

47 more — sign in →

All 52 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 132 Diabetes, Gestational studies recruiting now, 60 (45%) set no upper age limit and 70 (53%) stop at 75 or younger; 12 take children under 18; 60 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 251 studies in Diabetes, Gestational with a site in United States, or all of them as a file.
02

Study summary

The goal of this observational study is to learn how a physically active lifestyle during pregnancy affects placental development and function. The main question it aims to answer is:

Does regular physical activity during pregnancy improve placental function and support healthy fetal growth?

Pregnant participants will provide biological samples and health information during pregnancy and at delivery. The study will use these samples to examine how activity levels relate to placental energy production and overall health.

Read the detailed description

This observational study aims to examine how a physically active lifestyle during pregnancy affects placental function and fetal development. We will enroll pregnant participants and collect biological samples, including blood and placental tissue after delivery. The study will measure markers of placental energy production and other indicators of placental health to understand the mechanisms by which maternal physical activity may influence fetal growth.

Data collected will also include health information, lifestyle questionnaires, and activity assessments during pregnancy. Participants will not need to change their normal exercise habits. The results of this study may help identify how maternal physical activity supports placental and fetal health, which could inform future recommendations for healthy pregnancies.

03

Conditions studied

  • Pregnant Women
  • Gestational Diabetes
  • Obese But Otherwise Healthy Participants
  • Overweight (BMI > 25)
  • Gestational Diabetes Mellitus in Pregnancy

Keywords

  • maternal exercise
  • gestational diabetes
  • maternal physical activity
  • pregnancy
  • placental function
  • fetal development
  • maternal obesity
  • observational study
  • placental mitochondria
  • lifestyle intervention
  • pregnancy outcomes
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of pregnant individuals receiving prenatal care and/or delivering at affiliated clinical sites of the University of Maryland, Baltimore and surrounding community healthcare settings. Participants will be recruited from local obstetric clinics and hospital-based prenatal care programs. The study represents a community-based sample of pregnant individuals with varying levels of physical activity during pregnancy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant female and their newborn infant(s)
  • Aged 18-45 (pregnant female), age 0-60 days of life (newborn infant)
  • English speaking
  • Screened for gestational diabetes with standard glucose tolerance test between 24w - 41w gestation
  • Delivered at gestational age 34week-41weeks
  • Delivered via non-emergent Cesarean section during weekday hours
  • No known infectious disease (ex: , HepC)

Exclusion criteria

Exclusion Criteria:

  • Women \<18yo or >45yo
  • Non-English speaking
  • Pre-existing diabetes or diagnosed with diabetes prior to 24weeks
  • Required complex diets/supplements not related to the pregnancy (i.e. malnutrition)
  • Known severe fetal anomalies or genetic disorder
  • Placenta accreta spectrum
  • Emergent cesarean delivery performed due to fetal distress
  • Known infectious disease (ex: , HepC)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Target follow-up
2 Days
Patient registry
Yes
Biospecimen retention
Samples with dna

Groups and cohorts

  • Con

    pre-pregnancy BMI 18.5-24.9, no gestational diabetes

    Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)

  • overweight/obesity group

    pre-pregnancy BMI of 25 or greater, no gestational diabetes

    Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)

  • Gestational DM group

    pre-pregnancy BMI 18.5-24.9 with gestational diabetes

    Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)

  • gestational DM + overweight/obesity group

    pre-pregnancy BMI of 25 or greater, with gestational diabetes

    Behavioral: Pregnancy Physical Activity Questionnaire (PPAQ)

Interventions

  • BehavioralPregnancy Physical Activity Questionnaire (PPAQ)

    The PPAQ is a semiquantitative questionnaire that asks respondents to report the time spent participating in 32 activities including household/caregiving (13 activities),occupational (5 activities), sports/exercise (8 activities), transportation (3 activities), and inactivity (3 activities). For each activity, respondents are asked to select the category that best approximates the amount of time spent in that activity per day or week during the currenttrimester. Possible durations range from 0 to 6 or more hours per day and from 0 to 3 or more hours per week.

06

What researchers measure

Primary outcomes

  1. Placental mitochondrial function

    Placental mitochondrial function will be assessed using markers of mitochondrial biogenesis and energy metabolism measured in placental tissue collected at delivery. Outcomes will be examined in relation to maternal physical activity levels during pregnancy.

    Time frame: At delivery

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Results of our study will not be shared with the subjects. We plan on publishing our results in a peer reviewed journal. We also plan to present the results as a thesis dissertation for Dr. Esteves. We also hope the results will generate evidence for benefits of physical activity during pregnancy, which will lead to seeking extramural NIH grants for cohort study of pregnant women with exercise programs.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Dec 2026, 38 months after the start.

Of 142 non-industry observational studies under Diabetes, Gestational, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 70. This study's planned 38 months is close to that.

Counting every sponsor, half of 144 studies reached it within 43 months; a quarter within 19 and three quarters within 73.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2026
First posted
Jan 21, 2026
StartActual
Oct 18, 2023
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2027
Last update
Jan 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07356180
Responsible party
Jun Seok Son (Assistant Professor, University of Maryland, Baltimore) — Principal investigator
First posted
Jan 21, 2026
Start date
Oct 18, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jan 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion